Company Profiles

driven by the PitchBook Platform

OncoPep

OncoPep
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
PE Growth LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Developer of a therapeutic cancer vaccine designed for immuno-therapeutics against cancer. The company's therapeutic cancer vaccine are developed through a unique combination of proprietary peptides employing to stimulate the patient's immune system to attack his or her cancer through an optimized combination of disease-specific peptides and substances that stimulate the immune system.

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
520 Boston Street
North Andover, MA 01845
United States

+1 (978) 000-0000

OncoPep Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore OncoPep‘s full profile, request access.

Request full access to PitchBook

OncoPep Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore OncoPep‘s full profile, request access.

Request full access to PitchBook

OncoPep Executive Team (3)

Name Title Board
Seat
Contact
Info
Doris Peterkin Chief Executive Officer & Board Member
Jooeun Bae Ph.D Scientific Co-Founder & Advisor
Nikhil Munshi MD Scientific Co-Founder, Advisor & Board Member

OncoPep Board Members (9)

Name Representing Role Since Contact
Info
00000 000000 00 Self Board Member 000 0000
00000 00000000 OncoPep Chief Executive Officer & Board Member 000 0000
00000 000000000 00.0 Self Board Member 000 0000
000 0000000 00.0 EG Capital Group Board Member 000 0000
000000 000000 OncoPep Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com